Jana Ihlow

984 total citations · 1 hit paper
26 papers, 363 citations indexed

About

Jana Ihlow is a scholar working on Oncology, Hematology and Infectious Diseases. According to data from OpenAlex, Jana Ihlow has authored 26 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Hematology and 7 papers in Infectious Diseases. Recurrent topics in Jana Ihlow's work include Acute Myeloid Leukemia Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (4 papers). Jana Ihlow is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (4 papers). Jana Ihlow collaborates with scholars based in Germany, United States and South Korea. Jana Ihlow's co-authors include David Horst, Sefer Elezkurtaj, Helena Radbruch, Victor M. Corman, Selina Greuel, Catarina Alisa Kunze, Hermann Herbst, Florian Miller, Edward Michaelis and Philip Bischoff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Jana Ihlow

19 papers receiving 354 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes of death and comorbidities in hospitalized patients with COVID-19

2021 251 citations Sefer Elezkurtaj, Selina Greuel et al. Scientific Reports profile →

Peers

Countries citing papers authored by Jana Ihlow

Since Specialization

Citations

This map shows the geographic impact of Jana Ihlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Ihlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Ihlow more than expected).

Fields of papers citing papers by Jana Ihlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Ihlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Ihlow. The network helps show where Jana Ihlow may publish in the future.

Co-authorship network of co-authors of Jana Ihlow

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Ihlow. A scholar is included among the top collaborators of Jana Ihlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Ihlow. Jana Ihlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms of immune escape and extramedullary tropism in leukemia cutis 2025 ·Blood ·Livius Penter, Katie Maurer, Nicoletta Cieri, (unknown), (unknown), Mischa Selig, (unknown), Jana Ihlow, Shuqiang Li, Kenneth J. Livak, Lars Bullinger, Jerome Ritz, (unknown), Matthew S. Davids, Jacqueline S. Garcia, Robert J. Soiffer, Catherine J. Wu	0
2	Multiregional single-cell transcriptomics reveals an association between partial EMT and immunosuppressive states in oral squamous cell carcinoma 2025 ·iScience ·(unknown), (unknown), Dahee Kim, Jinho Jang, (unknown), Nam Suk Sim, Mischa Selig, Jana Ihlow, Livius Penter, (unknown), (unknown), (unknown), Jae Woong Lee, Young Min Park, Semin Lee, Yoon Woo Koh	1
3	A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass 2024 ·The Oncologist ·Stefan Habringer, Jana Ihlow, (unknown), (unknown), Max Schmidt, (unknown), Maren Knödler, Serge Leyvraz, (unknown), Bruno V. Sinn, Georg Maschmeyer, (unknown), Manuela Benary, Claus‐Eric Ott, Ingeborg Tinhofer, Reinhold Schäfer, Markus Möbs, Ulrich Keller, Ulrich Keilholz, Damian Rieke	0
4	Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI? 2024 ·Cancers ·(unknown), Felix Krenzien, (unknown), Dominik Geisel, Bernd Hamm, Uwe Pelzer, Jana Ihlow, Wenzel Schöning, Timo Alexander Auer, Uli Fehrenbach	0
5	Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis 2024 ·SHILAP Revista de lepidopterología ·Damian Rieke, (unknown), Jana Ihlow, (unknown), (unknown), Florian Nolte, Ulrich Keller, Sebastian Ochsenreither	0
6	Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy 2024 ·Blood Cancer Journal ·(unknown), Jana Ihlow, (unknown), (unknown), (unknown), (unknown), Michaela Schwarz, Anne Flörcken, Lam Vuong, Kathrin Rieger, Jan Krönke, Philipp le Coutre, (unknown), (unknown), David Horst, Thomas Burmeister, (unknown), Ulrich Keller, Lars Bullinger, Jörg Westermann	2
7	Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients 2024 ·European Journal Of Haematology ·Peter Nyvlt, Friederike S. Schuster, Jana Ihlow, (unknown), Claudia Spies, (unknown), Thomas Schenk, (unknown), Jörg Westermann, Frank M. Brunkhorst, Paul La Rosée, Gritta Janka, (unknown), Gunnar Lachmann	2
8	Prevalence of TERT Promoter Mutations in Orbital Solitary Fibrous Tumors 2024 ·Current Issues in Molecular Biology ·(unknown), Vladimir Kolpakov, Jana Ihlow, Maximilian von Laffert, (unknown), Hermann Herbst, (unknown), Leonille Schweizer, Eckart Bertelmann	1
9	Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling 2024 ·Med ·Jana Ihlow, Livius Penter, Lam Vuong, Philip Bischoff, Benedikt Obermayer, Alexandra Trinks, Olga Blau, Anke Behnke, Thomas Conrad, Markus Morkel, Catherine J. Wu, Jörg Westermann, Lars Bullinger, (unknown), Nils Blüthgen, David Horst, Samantha D. Praktiknjo	0
10	Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade 2023 ·Journal of Clinical Medicine ·Christopher Neumann, F Schneider, Georg Hilfenhaus, Loredana Vecchione, Christian Benzing, Jana Ihlow, Uli Fehrenbach, Thomas Malinka, Ulrich Keilholz, Sebastian Stintzing, Uwe Pelzer	5
11	Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade 2023 ·Cancers ·Christopher Neumann, F Schneider, Georg Hilfenhaus, Loredana Vecchione, Matthäus Felsenstein, Jana Ihlow, Dominik Geisel, (unknown), Johann Pratschke, Sebastian Stintzing, Ulrich Keilholz, Uwe Pelzer	11
12	Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization classification 2023 ·European Radiology ·Timo Alexander Auer, (unknown), Uli Fehrenbach, (unknown), Uwe Pelzer, Raphael Mohr, Bernd Hamm, Wenzel Schöning, David Horst, Jana Ihlow, Dominik Geisel	7
13	Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer 2022 ·Cancers ·Jana Ihlow, (unknown), Inga Hoffmann, Philip Bischoff, Bruno V. Sinn, Wolfgang Schmitt, Catarina Alisa Kunze, (unknown), Hagen Kulbe, Elena Ioana Braicu, Jalid Sehouli, Carsten Denkert, David Horst, Eliane T. Taube	8
14	COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis 2021 ·BMC Infectious Diseases ·Jana Ihlow, (unknown), Victor M. Corman, Achim D. Gruber, Simon Dökel, Jenny Meinhardt, Helena Radbruch, E. Späth‐Schwalbe, Sefer Elezkurtaj, David Horst, Hermann Herbst	4
15	Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients 2021 ·Scientific Reports ·Jan Matthias Kruse, Daniel Zickler, (unknown), Sophie K. Piper, Inka Gotthardt, Jana Ihlow, Selina Greuel, David Horst, Andreas Kahl, Kai‐Uwe Eckardt, Sefer Elezkurtaj	9
16	COVID-19: Autopsy findings in six patients between 26 and 46 years of age 2021 ·International Journal of Infectious Diseases ·Selina Greuel, Jana Ihlow, Mihnea P. Dragomir, Simon Streit, Victor M. Corman, (unknown), (unknown), Jenny Meinhardt, Tom Aschman, Julia Schneider, (unknown), Catarina Alisa Kunze, Lukas Maurer, Helena Radbruch, Frank L. Heppner, David Horst, Sefer Elezkurtaj	9
17	Causes of death and comorbidities in hospitalized patients with COVID-19 breakdown → 2021 ·Scientific Reports ·Sefer Elezkurtaj, Selina Greuel, Jana Ihlow, Edward Michaelis, Philip Bischoff, Catarina Alisa Kunze, Bruno V. Sinn, Manuela Gerhold, Kathrin Hauptmann, Barbara Ingold‐Heppner, Florian Miller, Hermann Herbst, Victor M. Corman, Hubert Martin, Helena Radbruch, Frank L. Heppner, David Horst	251
18	B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased 2021 ·International Journal of Infectious Diseases ·Jana Ihlow, Edward Michaelis, Selina Greuel, (unknown), Annika Lehmann, Helena Radbruch, Jenny Meinhardt, Florian Miller, Hermann Herbst, Victor M. Corman, Jörg Westermann, Lars Bullinger, David Horst, (unknown), Sefer Elezkurtaj	14
19	Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decades 2020 ·Journal of Geriatric Oncology ·Jana Ihlow, (unknown), Nina Rosa Neuendorff, (unknown), (unknown), (unknown), Michaela Schwarz, Anne Flörcken, Ioannis Anagnostopoulos, Seval Türkmen, Thomas Burmeister, Igor Wolfgang Blau, Lars Bullinger, Jörg Westermann	8
20	Therapy‐Induced Senescence Is a Predictor of Treatment Outcome in Acute Myeloid Leukemia 2017 ·Blood ·Martin Schönlein, J. Henry M. Däbritz, Dorothy Ngo-Yin Fan, Jana Ihlow, Rolf Schwarzer, Binje Vick, Karsten Spiekermann, Thomas Burmeister, Jörg Westermann, Irmela Jeremias, Clemens A. Schmitt	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact